Stockscreener 앱 받기
8.00
6.67%
0.50
시간 외 거래:
7.80
-0.20
-2.50%
Seres Therapeutics Inc 주식(MCRB)의 최신 뉴스
CCORF Maintains Seres Therapeutics(MCRB.US) With Buy Rating, Maintains Target Price $22 - Moomoo
MSN Money - MSN
Seres Therapeutics 1Q 2026: Revenue $358K, EPS $(2.08) — 10-Q Summary - TradingView
Seres Therapeutics (NASDAQ: MCRB) Q1 2026 loss and going-concern risk - Stock Titan
Seres Therapeutics: Q1 Earnings Snapshot - marketscreener.com
Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
Seres Therapeutics (Nasdaq: MCRB) Q1 2026 results and cash runway - Stock Titan
Seres awaits SER-155 data in weeks with cash through Q3 - Stock Titan
Seres presents preclinical data on IBD drug candidate SER-603 - Investing.com UK
Seres presents preclinical data on IBD drug candidate SER-603 By Investing.com - Investing.com South Africa
Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease - The Manila Times
Experimental IBD microbiome therapy earns DDW poster honor - Stock Titan
Seres Therapeutics Presents Preclinical Data at Digestive - GlobeNewswire
MCRB stock declines as Seres Therapeutics pauses SER-155 phase 2 study and shrinks headcount by 30% - MSN
Seres Therapeutics (MCRB) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Equity plan and director votes in Seres Therapeutics (NASDAQ: MCRB) 2026 proxy - Stock Titan
Microbiome Therapeutics Market is Going to Booming Growth - openPR.com
Chardan Capital Downgrades Seres Therapeutics (MCRB) - MSN
MCRB Price Today: Seres Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat
Seres Therapeutics (MCRB) Presents Key Data at ESCMID Congress - GuruFocus
Seres Therapeutics (MCRB) Showcases Research at ESCMID 2026 Cong - GuruFocus
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 - The Manila Times
Seres spotlights microbiome data for transplant patients at ESCMID - Stock Titan
Aug Catalysts: Is Seres Therapeutics Inc impacted by rising rates2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn
Seres Therapeutics Stock Price Drops Below 50-Day Average - National Today
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Will Seres Therapeutics Inc benefit from green energy policies2026 Chart Watch & High Accuracy Trade Alerts - baoquankhu1.vn
Is Seres Therapeutics (MCRB) Stock a Buy Now | Price at $8.51, Down 2.34%Volume Leaders - Newser
Seres Therapeutics to Present at CARB-X Investor Day - Bitget
Seres brings CARB-X-backed ICU infection therapy to Munich event - Stock Titan
Aug Ideas: Should I invest in Seres Therapeutics Inc before earnings2026 Setups & Low Drawdown Trading Strategies - baoquankhu1.vn
VIX Spike: Does Seres Therapeutics Inc have declining or rising EPSWeekly Stock Analysis & Daily Entry Point Alerts - baoquankhu1.vn
MCRB SEC FilingsSeres Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What are the biggest risks for Seres Therapeutics (MCRB) Stock | Price at $9.27, Up 4.63%Capital Preservation - Cổng thông tin điện tử tỉnh Lào Cai
Market Fear: Can Seres Therapeutics Inc weather a recessionDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn
Market Rankings: Is Seres Therapeutics Inc in a bullish channelTrade Volume Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
Layoff Tracker: Takeda Restructuring Will Affect Workforce, Could Include Layoffs - BioSpace
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat
Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026 - MSN
Seres Therapeutics (MCRB) price target increased by 31.25% to 21.42 - msn.com
If You Invested $1,000 in Seres Therapeutics Inc (MCRB) - Stock Titan
1.77%
0.25%
자본화:
|
볼륨(24시간):